[Cytostatic therapy of malignant lymphoma].
D000293:Adolescent; D000470:Alkaloids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use
D000470:Alkaloids; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds
Zytostatische Therapie der malignen Lymphome.